Literature DB >> 29103990

A Call to Arms: Quest for a Cryptococcal Vaccine.

Marley C Caballero Van Dyke1, Floyd L Wormley2.   

Abstract

Cryptococcosis remains a significant cause of morbidity and mortality world-wide, particularly among AIDS patients. Yet, to date, there are no licensed vaccines clinically available to treat or prevent cryptococcosis. In this review, we provide a rationale to support continued investment in Cryptococcus vaccine research, potential challenges that must be overcome along the way, and a literature review of the current progress underway towards developing a vaccine to prevent cryptococcosis.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cryptococcus; Cryptococcus gattii; Cryptococcus neoformans; cryptococcal vaccine; cryptococcosis

Mesh:

Substances:

Year:  2017        PMID: 29103990      PMCID: PMC5910246          DOI: 10.1016/j.tim.2017.10.002

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  115 in total

1.  Hyporesponsiveness to natural killer T-cell ligand alpha-galactosylceramide in cancer-bearing state mediated by CD11b+ Gr-1+ cells producing nitric oxide.

Authors:  Kazuhiko Yanagisawa; Mark A Exley; Xiaofeng Jiang; Nobuhiro Ohkochi; Masaru Taniguchi; Ken-ichiro Seino
Journal:  Cancer Res       Date:  2006-12-01       Impact factor: 12.701

2.  Mannoproteins from Cryptococcus neoformans promote dendritic cell maturation and activation.

Authors:  Donatella Pietrella; Cristina Corbucci; Stefano Perito; Giovanni Bistoni; Anna Vecchiarelli
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

3.  A 77-kilodalton protein of Cryptococcus neoformans, a member of the heat shock protein 70 family, is a major antigen detected in the sera of mice with pulmonary cryptococcosis.

Authors:  H Kakeya; H Udono; N Ikuno; Y Yamamoto; K Mitsutake; T Miyazaki; K Tomono; H Koga; T Tashiro; E Nakayama; S Kohno
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

4.  Characterization of two novel cryptococcal mannoproteins recognized by immune sera.

Authors:  Carmelo Biondo; Luciano Messina; Mauro Bombaci; Giuseppe Mancuso; Angelina Midiri; Concetta Beninati; Valentina Cusumano; Elisabetta Gerace; Salvatore Papasergi; Giuseppe Teti
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

Review 5.  Spread of Cryptococcus gattii into Pacific Northwest region of the United States.

Authors:  Kausik Datta; Karen H Bartlett; Rebecca Baer; Edmond Byrnes; Eleni Galanis; Joseph Heitman; Linda Hoang; Mira J Leslie; Laura MacDougall; Shelley S Magill; Muhammad G Morshed; Kieren A Marr
Journal:  Emerg Infect Dis       Date:  2009-08       Impact factor: 6.883

6.  A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam - high prevalence of Cryptococcus neoformans var grubii in the absence of underlying disease.

Authors:  Tran Th Chau; Nguyen H Mai; Nguyen H Phu; Ho D Nghia; Ly V Chuong; Dinh X Sinh; Van A Duong; Pham T Diep; James I Campbell; Stephen Baker; Tran T Hien; David G Lalloo; Jeremy J Farrar; Jeremy N Day
Journal:  BMC Infect Dis       Date:  2010-07-09       Impact factor: 3.090

Review 7.  Cryptococcosis in solid organ transplant recipients: current state of the science.

Authors:  Nina Singh; Francoise Dromer; John R Perfect; Olivier Lortholary
Journal:  Clin Infect Dis       Date:  2008-11-15       Impact factor: 9.079

8.  Immunization of mice with stable, acapsular, yeast-like mutants of Cryptococcus neoformans.

Authors:  R A Fromtling; A M Kaplan; H J Shadomy
Journal:  Sabouraudia       Date:  1983-06

9.  Vaccine and immunotherapeutic approaches for the prevention of cryptococcosis: lessons learned from animal models.

Authors:  Camaron R Hole; Floyd L Wormley
Journal:  Front Microbiol       Date:  2012-08-28       Impact factor: 5.640

10.  Hsp90 orchestrates stress response signaling governing fungal drug resistance.

Authors:  Leah E Cowen
Journal:  PLoS Pathog       Date:  2009-08-28       Impact factor: 6.823

View more
  18 in total

1.  Exploring Cryptococcus neoformans capsule structure and assembly with a hydroxylamine-armed fluorescent probe.

Authors:  Conor J Crawford; Radamés J B Cordero; Lorenzo Guazzelli; Maggie P Wear; Anthony Bowen; Stefan Oscarson; Arturo Casadevall
Journal:  J Biol Chem       Date:  2020-01-31       Impact factor: 5.157

2.  Vaccine protection by Cryptococcus neoformans Δsgl1 is mediated by γδ T cells via TLR2 signaling.

Authors:  Tyler G Normile; Timothy H Chu; Brian S Sheridan; Maurizio Del Poeta
Journal:  Mucosal Immunol       Date:  2022-10-13       Impact factor: 8.701

3.  Limited Role of Mincle in the Host Defense against Infection with Cryptococcus deneoformans.

Authors:  Yuki Sato; Ko Sato; Hideki Yamamoto; Jun Kasamatsu; Tomomitsu Miyasaka; Daiki Tanno; Anna Miyahara; Takafumi Kagesawa; Akiho Oniyama; Kotone Kawamura; Rin Yokoyama; Yuki Kitai; Aya Umeki; Shigenari Ishizuka; Kazuki Takano; Ryuhei Shiroma; Nana Nakahata; Kaori Kawakami; Emi Kanno; Hiromasa Tanno; Sho Yamasaki; Hiromitsu Hara; Keiko Ishii; Kazuyoshi Kawakami
Journal:  Infect Immun       Date:  2020-10-19       Impact factor: 3.441

Review 4.  Cryptococcus neoformans: Sex, morphogenesis, and virulence.

Authors:  Youbao Zhao; Xiaorong Lin
Journal:  Infect Genet Evol       Date:  2021-01-23       Impact factor: 3.342

Review 5.  Mechanisms of Pulmonary Escape and Dissemination by Cryptococcus neoformans.

Authors:  Steven T Denham; Jessica C S Brown
Journal:  J Fungi (Basel)       Date:  2018-02-17

6.  Differential Effects of Linkers on the Activity of Amphiphilic Tobramycin Antifungals.

Authors:  Marina Y Fosso; Sanjib K Shrestha; Nishad Thamban Chandrika; Emily K Dennis; Keith D Green; Sylvie Garneau-Tsodikova
Journal:  Molecules       Date:  2018-04-13       Impact factor: 4.411

7.  Induction of memory-like dendritic cell responses in vivo.

Authors:  Camaron R Hole; Chrissy M Leopold Wager; Natalia Castro-Lopez; Althea Campuzano; Hong Cai; Karen L Wozniak; Yufeng Wang; Floyd L Wormley
Journal:  Nat Commun       Date:  2019-07-04       Impact factor: 14.919

8.  iNOS/Arginase-1 expression in the pulmonary tissue over time during Cryptococcus gattii infection.

Authors:  Patrícia Kellen Martins Oliveira-Brito; Caroline Patini Rezende; Fausto Almeida; Maria Cristina Roque-Barreira; Thiago Aparecido da Silva
Journal:  Innate Immun       Date:  2019-08-25       Impact factor: 2.680

Review 9.  Innate Inspiration: Antifungal Peptides and Other Immunotherapeutics From the Host Immune Response.

Authors:  Derry K Mercer; Deborah A O'Neil
Journal:  Front Immunol       Date:  2020-09-17       Impact factor: 7.561

10.  IFN-γ immune priming of macrophages in vivo induces prolonged STAT1 binding and protection against Cryptococcus neoformans.

Authors:  Chrissy M Leopold Wager; Camaron R Hole; Althea Campuzano; Natalia Castro-Lopez; Hong Cai; Marley C Caballero Van Dyke; Karen L Wozniak; Yufeng Wang; Floyd L Wormley
Journal:  PLoS Pathog       Date:  2018-10-10       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.